National Cancer Center;Eisai R&D Management Co., Ltd.
发明人:
申请号：
EP16768810.0
公开号：
EP3275442A1
申请日:
2016.03.23
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention provides a therapeutic agent for bile duct cancer comprising 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof.
